Some Abbott Molecular Inc. Alinity COVID-19 laboratory tests may falsely diagnose patients with the SARS-CoV-2 virus. The US Food and Drug Administration says health care providers should consider redoing tests to decrease the chances of being misdiagnosed.
The FDA on 17 September said it has notified health care providers that the Alinity m SARS-CoV-2 AMP and Alinity...